Fujirebio Diagnostics’ blood test for Alzheimer’s disease offers a less expensive and less invasive alternative compared to medical imaging and tests of cerebrospinal fluid. But competition looms from blood-based tests in development by other diagnostics companies. The post Alzheimer’s Disease Now Has Its First FDA-Cleared Blood Test appeared first on MedCity News.
Omada Health filed for an IPO on Friday. It’s the second major digital health company to do so this year, following musculoskeletal company Hinge Health in March. The post Omada Health Files to Go Public: Will It Be Successful? appeared first on MedCity News.
KFF Health News contributor Andy Miller discussed the Trump presidency and health care on WUGA’s “The Georgia Health Report” on Nov. 8. Click here to hear Miller on “The Georgia Health Report” Read Stephanie Armour’s “Trump’s White House Return Poised To Tangle Health Care Safety Net” KFF Health News correspondent Brett Kelman discussed dental implants…
Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates. The post Merck Is Paying $588M for…
NASHVILLE, Tenn. — Federal prosecutors sought a maximum prison sentence of nearly 20 years for the CEO of Pain MD, a company found to have given hundreds of thousands of questionable injections to patients, many reliant on opioids. It would have been among the longest sentences for a health care executive convicted of fraud in…
Highmark and Sword Health launched a new virtual pelvic health offering on Monday. The program connects members with a pelvic health specialist. The post Highmark Launches Virtual Pelvic Health Offering Powered by Sword Health appeared first on MedCity News.
At the global health conference in Las Vegas, panelists discuss innovation and metrics for success
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program. The post Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing appeared first on MedCity…
KFF Health News editor-at-large for public health Céline Gounder discussed a mysterious illness in Congo that has claimed dozens of lives on CBS’ “CBS Mornings” on Feb. 26. Click here to watch Gounder on “CBS Mornings” KFF Health News chief Washington correspondent Julie Rovner discussed moves by Secretary of Health and Human Services Robert F….
While advancements in diagnostics are promising, the need remains for healthcare professionals to take the lead on proactive conversations with patients and their loved ones about the early signs and symptoms of Alzheimer’s disease. The post Transforming Our Collective Approach to Alzheimer’s Disease Care Begins with Early and Accurate Diagnosis appeared first on MedCity News.